Hussman Strategic Advisors Inc. Acquires Shares of 105,000 Phibro Animal Health Co. (NASDAQ:PAHC)

Hussman Strategic Advisors Inc. acquired a new stake in Phibro Animal Health Co. (NASDAQ:PAHC) during the 4th quarter, Holdings Channel reports. The institutional investor acquired 105,000 shares of the company’s stock, valued at approximately $2,205,000.

Other hedge funds have also made changes to their positions in the company. Geode Capital Management LLC grew its position in shares of Phibro Animal Health by 5.7% during the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after buying an additional 27,201 shares in the last quarter. Barclays PLC grew its position in shares of Phibro Animal Health by 25.7% during the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after buying an additional 29,271 shares in the last quarter. Algert Global LLC grew its position in shares of Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after buying an additional 59,850 shares in the last quarter. FMR LLC grew its position in shares of Phibro Animal Health by 22.7% during the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after buying an additional 7,270 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its position in shares of Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after buying an additional 729 shares in the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

Shares of PAHC stock opened at $24.17 on Thursday. Phibro Animal Health Co. has a 1-year low of $11.90 and a 1-year high of $26.55. The stock’s 50-day moving average is $22.23 and its 200 day moving average is $22.06. The company has a market cap of $978.89 million, a P/E ratio of 50.35, a PEG ratio of 0.51 and a beta of 0.52. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Research analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.99%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is presently 100.00%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Barclays raised their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. Finally, Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.